ONC · Categories · Upgrades
ONC - Analyst upgrades
BeOne Medicines Ltd. (ONC) analyst upgrades - real-time wire coverage filtered to Upgrades only.
Recent Upgrades for ONC
- BeOne Medicines upgraded by Jefferies with a new price targetJefferies upgraded BeOne Medicines from Hold to Buy and set a new price target of $380.00
- BeiGene upgraded by BofA Securities with a new price targetBofA Securities upgraded BeiGene from Neutral to Buy and set a new price target of $320.00 from $207.00 previously